LOCAL SCIENTIFIC & HOST COMMITTEE
Karl-Johan Malmberg, Oslo University Hospital
Lise Kveberg, University of Oslo
Erik Dissen, University of Oslo
Marit Inngjerdingen, University of Oslo
Yenan Bryceson, Karolinska Institutet, Stockholm, Sweden
Michael Daws, University of Oslo
Clinical Day at #NK2023 is finally here, officially opened by Kalle Malmberg, we are all super excited to learn the latest on clinical developments on NK cells!
💡👁️a swell Idea for seeing cells:
#UnclearingMicroscopy
physically inflates and then stains cells,
bypassing need for expensive microscopes
🔗https://t.co/exDpFUI3W5
🔗https://t.co/eN0YIddOy8
💬 super-resolution🔬without state-of-the-art
🖼️@OnsMSaad1 🔗https://t.co/q0FUuyJET4
Gripende om forskning og langsiktig håp i @Amagasinet
@Magnarbjoras:
"alle dem som lever med sjeldne, arvelige sykdommer i Norge (..er..)
over 200 000 mennesker" https://t.co/LtTwO7wQWQ
v/Robert Veiåker Johansen
@jarlebreivik@heidiry@UniOslo_MED@atferdsmedisin What if your oncologist lacks time?
Informs that cancer has spread to skeleton.
But rushes to his next task.
Leaving patient & wife with unanswered questions.
This happened last Friday at @Oslounivsykehus
Moreover, can you trust he has time to figure out best treatment options?
Really happy to start 2023 with the publication of our work in @NatureComms! 🤩 We show that IL-1β/IL-1rn balance controls HSC differentiation, and that low IL-1RN may originate and worsen hematopoietic disease, and predicts poor survival in AML patients https://t.co/Z2a3OGGetK